A 1:5 ratio of cannabigerol (CBG) to the terpene phytol significantly reduced bile acid-induced DNA damage, oxidative stress, and mutagenicity in esophageal cells, while CB1 receptor expression correlated with esophageal cancer progression in patient samples.
Gastroenterology researchers, cancer prevention scientists, and cannabinoid researchers studying the entourage effect.
What the researchers found
The CBG:Phytol 1:5 ratio reduced DCA-induced DNA damage, preserved mitochondrial membrane potential, decreased reactive oxygen species, enhanced apoptosis in damaged cells, and reduced mutagenicity. Patient sample analysis showed CB1 receptor expression correlated with esophageal adenocarcinoma progression.
Why it matters
Esophageal adenocarcinoma arises from chronic acid reflux damage. If cannabinoid-terpene combinations can reduce the mutagenic damage that drives this progression, they could represent a preventive strategy for people with Barrett's esophagus, a known cancer precursor.
The numbers in context
Optimal ratio: 1:5 CBG to Phytol. Reduced DCA-induced DNA damage, ROS, and mutagenicity. CB1 expression correlated with EAC progression in patient samples.
How the study worked
In vitro models using human esophageal epithelial cells exposed to deoxycholic acid (bile acid) and a Barrett's esophagus gastroesophageal reflux model. Various cannabinoid-terpene ratios tested. Patient-derived tissue samples analyzed for ECS receptor expression.
What this study cannot tell us
Preprint (not yet peer-reviewed). In vitro models do not replicate the complexity of chronic reflux disease. The CBG:Phytol ratio was found through screening, not mechanistic optimization. Patient tissue analysis was correlative.
How to read the evidence
Novel finding combining in vitro screening with patient tissue analysis, but preprint status and in vitro design limit evidence strength.
When this study was published
2025 preprint.
The bigger picture
This study bridges the entourage effect concept with cancer prevention, showing that specific cannabinoid-terpene ratios are more effective than individual compounds. The CB1 receptor's correlation with cancer progression suggests the endocannabinoid system is already active in this disease process.
Questions still open
- Would oral CBG:Phytol supplements reduce esophageal cancer risk in Barrett's esophagus patients?
- Is CB1 receptor expression a useful biomarker for esophageal cancer risk?
Common questions
What is phytol?
What is Barrett's esophagus?
Read the original research
Optimal Cannabinoid-Terpene Combination Ratios Suppress Mutagenicity of Gastric Reflux in Normal and Metaplastic Esophageal Cells.
bioRxiv : the preprint server for biology
Citation
Goldman, Aaron; Gonzalez, Gabriel; Karpova, Svetlana A; Buon, Leutz; Shammas, Masood A; Mashimo, Hiroshi; Frank, Markus H; Frank, Natasha Y. (2025). Optimal Cannabinoid-Terpene Combination Ratios Suppress Mutagenicity of Gastric Reflux in Normal and Metaplastic Esophageal Cells.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.09.23.678062
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk